✦ LIBER ✦

Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era

✍ Scribed by Ryan S. Turley; Peter D. Peng; Srinevas K. Reddy; Andrew S. Barbas; David A. Geller; J. Wallis Marsh; Allan Tsung; Timothy M. Pawlik; Bryan M. Clary

Book ID: 112066978
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 144 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26650

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of gastrointestinal stromal t

Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors

✍ Suzanne George; Jayesh Desai 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 274 KB

Has the Survival Rate for Surgically Res

Has the Survival Rate for Surgically Resected Gastric Gastrointestinal Stromal Tumors Improved in the Tyrosine Kinase Inhibitor Era?

✍ Pedroso, Felipe E.; Raut, Chandrajit P.; Xiao, Hong; Yeo, Charles J.; Koniaris, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 436 KB

Cardiovascular Effects of Tyrosine Kinas

Cardiovascular Effects of Tyrosine Kinase Inhibitors Used for Gastrointestinal Stromal Tumors

✍ Chintalgattu, Vishnu; Patel, Shalin S.; Khakoo, Aarif Y. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Differential Properties of Current Tyros

Differential Properties of Current Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors

✍ George D. Demetri 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Sunitinib, a multitargeted tyrosine kina

Sunitinib, a multitargeted tyrosine kinase inhibitor, in the management of gastrointestinal stromal tumor

✍ Suzanne George 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 243 KB

Molecular basis for primary and secondar

Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor

✍ Mrinal M. Gounder; Robert G. Maki 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 744 KB